Delivery Order SPE2DR25D2005-SPE2DR26FE7P3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,131.84 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 20, 2025, with completion targeted for November 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. As a child order under a larger contract vehicle, this delivery exemplifies the...
- The Defense Logistics Agency awarded a delivery order valued at $1,889.08 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,395.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the...
- The Defense Logistics Agency awarded a $1,882.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 20, 2025, with completion scheduled for November 21, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.94 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger prime contract vehicle with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 count) valued at $4,034.24 on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, non-set-aside contract was issued on a firm fixed-price basis and represents a child delivery order under a larger contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $1,740.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units). Issued on September 16, 2025, with an ultimate completion date of September 17, 2025, this competitively awarded contract required no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,044.04 to AmerisourceBergen Drug Corp for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This is a firm fixed price, non-competitive delivery order that was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,145.00 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 12, 2025, with completion scheduled for November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,668.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7P3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,011.14 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on November 25, 2025, with an ultimate completion date of November 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC, designated SPE2DX, serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, has demonstrated substantial capability in fulfilling federal medical supply requirements across multiple therapeutic domains through its extensive portfolio of competitive contract awards with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/24/25 |